Dermatologia
Vitamina B3, niacinamida e redução do risco de câncer de pele: o que dizem as pesquisas?
23 Mar, 2022 | 11:28hConteúdo relacionado: A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention – New England Journal of Medicine
Revisão sistemática | Estratégias para uso tópico de corticosteroides em crianças e adultos com eczema.
22 Mar, 2022 | 11:33hStrategies for using topical corticosteroids in children and adults with eczema – Cochrane Library
Resumo: What is the best way to use topical corticosteroids to treat people with eczema? – Cochrane Library
Comentário no Twitter
What is the best way to use topical #corticosteroids to treat people with #eczema?
"Generally, stronger topical corticosteroids are probably more effective than weaker preparations". https://t.co/iaH6fzyXL4Read the latest evidence from @CochraneSkin @CebdNottm pic.twitter.com/f01BO2FyDs
— Cochrane UK (@CochraneUK) March 17, 2022
Estudo randomizado fase 2 | Uso profilático de garadacimabe em pacientes com angioedema hereditário.
21 Mar, 2022 | 16:08hProphylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário: Garadacimab significantly reduces frequency of hereditary angioedema exacerbations – Physician’s Weekly
Estudo randomizado | Contezolida oral vs. linezolida em adultos com infecções cutâneas e de partes moles complicadas.
21 Mar, 2022 | 15:58hA Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link para o resumo – $ para o texto completo)
Comentário no Twitter
Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
📌Non inferior
📌Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
📌QIDP https://t.co/wSvxUInnkZ— Antibiotic Steward Bassam Ghanem (@ABsteward) March 11, 2022
Seguimento de dados de 2 estudos randomizados | Eficácia e segurança do uso de upadacitinibe em pacientes com dermatite atópica moderada a grave.
21 Mar, 2022 | 15:55hRevisão sistemática | Intervenções sistêmicas para tratamento da síndrome de Stevens-Johnson (SSJ), da necrólise epidermal tóxica (NET) e da síndrome de sobreposição SSJ/NET.
14 Mar, 2022 | 13:49hRevisão | Infecção cutânea por micobactérias.
14 Mar, 2022 | 13:40hMycobacterial skin infection – Current Opinion in Infectious Diseases
Estudo randomizado | Comparativo entre metotrexato em monoterapia e metotrexato combinado com leflunomida para a artrite psoriática.
10 Mar, 2022 | 15:33hComparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial – The Lancet Rheumatology (link para o resumo – $ para o texto completo)
Comentário:
Comentário no Twitter
NEW RESEARCH—A double-blind, placebo-controlled, randomised, trial comparing monotherapy with methotrexate plus #leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA) https://t.co/Fln7RlNl36 #LancetRheumatology pic.twitter.com/EqWSeHZQA2
— The Lancet Rheumatology (@TheLancetRheum) March 3, 2022
Diretriz | Diagnóstico e tratamento do vitiligo.
8 Mar, 2022 | 18:25hS1 Guideline: Diagnosis and therapy of vitiligo – Journal of the German Society of Dermatology
Artigos de revisão | Manifestações cutâneas da infecção pelo SARS-CoV-2.
8 Mar, 2022 | 17:43hCutaneous Manifestations of SARS-CoV-2 Infection – American Journal of Clinical Dermatology
Common skin signs of COVID-19 in adults: An update – Cleveland Clinic Journal of Medicine